Launa J. Aspeslet

Health Technology

Consumer Services

Profile

Launa J.
Aspeslet served as the Chief Executive Officer at Translational Research In Oncology from 2015 to 2022.
Prior to that, she was the Chief Operating Officer & Head-Investor Relations at Isotechnika Pharma, Inc. from 2009 to 2013.
She also held the position of Chief Operating Officer at Aurinia Pharmaceuticals, Inc. Additionally, she is currently serving as the Chief Operating Officer at Hepion Pharmaceuticals, Inc. starting from 2022.
Dr. Aspeslet holds a doctorate degree from the University of Alberta, which she obtained in 1994.
She also completed her undergraduate studies at the University of Lethbridge in 1989.

Former positions of Launa J. Aspeslet

Companies	Position	End
HEPION PHARMACEUTICALS, INC.	Chief Operating Officer	2023-12-31
Translational Research In Oncology	Chief Executive Officer	2022-04-30
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Chief Operating Officer	2013-10-22
AURINIA PHARMACEUTICALS INC.	Chief Operating Officer	-

See the detail of Launa J. Aspeslet's experience

Training of Launa J. Aspeslet

University of Alberta	Doctorate Degree
University of Lethbridge	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Launa J. Aspeslet's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
HEPION PHARMACEUTICALS, INC.	Health Technology
AURINIA PHARMACEUTICALS INC.	Health Technology

Private companies	2
Isotechnika Pharma, Inc. Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.	Health Technology
Translational Research In Oncology